Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19
Completed
- Conditions
- Respiratory Distress Syndrome
- Registration Number
- NCT04343404
- Lead Sponsor
- University Hospital, Strasbourg, France
- Brief Summary
Describe COVID-19 patients who are receiving ECMO-VV respiratory replacement and what happens to them.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- Patient over the age of 18;
- Diagnostic COVID-19 by RT-PCR;
- Hospitalisation in resuscitation for the management of complications related to COVID-19
- Implanted ECMO-VV during hospitalisation;
- Patient agreeing to participate in the study
Exclusion Criteria
- Sujet under guardianship or trusteeship
- Sujet under safeguard of justice
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Retrospective description of COVID-19 patients receiving respiratory ECMO-VV supplementation and what happens to them Files analysed retrospectily from March 1st, 2020 to April 15, 2020 will be examined
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Service de Chirurgie Thoracique Nouvel Hôpital Civil Hôpitaux Universitaires de Strasbourg
🇫🇷Strasbourg, France